These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 922116

  • 21. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
    Hoffman GS, Kline I, Gang M, Tyrer DD, Goldin A, Mantel N, Venditti JM.
    Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
    [No Abstract] [Full Text] [Related]

  • 22. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with "S" phase sensitive drugs.
    Alate AD, Khandalekar DD, Amonkar AJ, Adwankar MK, Sahasrabudhe MB.
    Biomedicine; 1978 Oct; 28(5):270-3. PubMed ID: 743552
    [Abstract] [Full Text] [Related]

  • 23. Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia.
    Wampler GL, Carter WH, Campbell ED, Goldman ID.
    Cancer Treat Rep; 1987 Jun; 71(6):581-91. PubMed ID: 3581096
    [Abstract] [Full Text] [Related]

  • 24. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
    Grossie VB, Rosenblum MG, Loo TL.
    Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
    [Abstract] [Full Text] [Related]

  • 25. Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.
    Venditti JM, Baratta MC, Greenberg NH, Abbott BJ, Kline I.
    Cancer Chemother Rep; 1972 Aug; 56(4):483-92. PubMed ID: 5081591
    [No Abstract] [Full Text] [Related]

  • 26. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK, Fraser TJ, Day KJ.
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [Abstract] [Full Text] [Related]

  • 27. Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.
    Rustum YM, Dave C, Mayhew E, Papahadjopoulos D.
    Cancer Res; 1979 Apr; 39(4):1390-5. PubMed ID: 421223
    [No Abstract] [Full Text] [Related]

  • 28. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
    Yamagami K, Fujii A, Arita M, Okumoto T, Sakata S, Matsuda A, Ueda T, Sasaki T.
    Cancer Res; 1991 May 01; 51(9):2319-23. PubMed ID: 2015596
    [Abstract] [Full Text] [Related]

  • 29. Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-beta-D-arabinofuranosylcytosine.
    Scheving LE, Burns ER, Pauly JE, Halberg F, Haus E.
    Cancer Res; 1977 Oct 01; 37(10):3648-55. PubMed ID: 908013
    [Abstract] [Full Text] [Related]

  • 30. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Oct 01; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 31. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T, Szmigielska A.
    Neoplasma; 2000 Oct 01; 47(3):168-71. PubMed ID: 11043840
    [Abstract] [Full Text] [Related]

  • 32. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K, Sekido S, Araki T.
    Gan To Kagaku Ryoho; 1984 Jun 01; 11(6):1315-23. PubMed ID: 6428326
    [Abstract] [Full Text] [Related]

  • 33. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL, Roberts D.
    Eur J Cancer (1965); 1974 Jul 01; 10(7):425-9. PubMed ID: 4457345
    [No Abstract] [Full Text] [Related]

  • 34. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH, Stablein DM, Wampler GL.
    Cancer Res; 1979 Sep 01; 39(9):3446-53. PubMed ID: 476674
    [Abstract] [Full Text] [Related]

  • 35. Antitumor activity of prolonged-release derivative of cytosine arabinoside, cytosine arabinoside-agarose conjugate.
    Hashida M, Kojima T, Muranishi S, Sezaki H.
    Gan; 1978 Dec 01; 69(6):839-43. PubMed ID: 750275
    [Abstract] [Full Text] [Related]

  • 36. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K, Balzarini J, Sandvold ML, Myhren F, Martinsen M, De Clercq E, Fodstad O.
    Cancer Res; 1999 Jun 15; 59(12):2944-9. PubMed ID: 10383159
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL, Momparler LF.
    Cancer Chemother Pharmacol; 1989 Jun 15; 25(1):51-4. PubMed ID: 2480188
    [Abstract] [Full Text] [Related]

  • 38. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA, Hutchison DJ.
    Cancer Chemother Rep; 1972 Aug 15; 56(4):473-81. PubMed ID: 5081590
    [No Abstract] [Full Text] [Related]

  • 39. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I, Hara M, Ohmoto E, Oda Y, Endo Y, Fujimoto S, Uchida K, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S.
    Gan To Kagaku Ryoho; 1982 Sep 15; 9(9):1617-22. PubMed ID: 6964050
    [Abstract] [Full Text] [Related]

  • 40. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE, Straus MJ.
    Cancer Treat Rep; 1980 Jan 15; 64(1):81-6. PubMed ID: 7379059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.